Sara Pai, MD
Otolaryngology · New Haven, CTNPI 1093861429
Payments from drug & device makers
What this record shows
The money is spread across several categories — consulting fees (46.3%), travel and lodging and speaking fees — rather than concentrated in one kind of arrangement. Merck accounts for 88.0% of it on its own, with 3 other manufacturers making up the rest. Among otolaryngology clinicians in CT with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 118 payments — averaging $1352.51 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Merck$140K
- AbbVie$12K
- Precigen, Inc.$4K
- G1 Therapeutics, Inc.$3K
Across 55 payments — averaging $61,297 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Merck$3.1M
- AbbVie$160K
- AstraZeneca$99K
What the payments were for
- Consulting fees$73,93346%
- Speaking & faculty fees$22,80014%
- Travel & lodging$59,74637%
- Food & beverage$1,4301%
- Education$1,6891%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Merck | 104 | $140,386 |
| AbbVie | 6 | $12,052 |
| Precigen, Inc. | 7 | $3,679 |
| G1 Therapeutics, Inc. | 1 | $3,480 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- KEYTRUDA$50,306
- GARDASIL 9$3,844
- COSELA$3,480
- PAPZIMEOS$3,381
- LENVIMA$1,373
How this compares
$159,597 in reported general payments places this provider in the 95th percentile of 119 otolaryngology providers in Connecticut.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other otolaryngology in New Haven
- Richard ManesNew Haven$67K
- Howard BoeyNew Haven$19K
- Wendell YarbroughNew Haven$6K
- Ken YanagisawaNew Haven$5K
- Mark DagostinoNew Haven$5K
- Clarence SasakiNew Haven$5K
- Eaton ChenNew Haven$4K
- Tiffany ChenNew Haven$3K
- Catherine BrophyNew Haven$3K
- Paul FortgangNew Haven$3K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.